ESTRO meets Asia 2024 - Abstract Book

S331

Physics – Motion management and adaptive radiotherapy

ESTRO meets Asia 2024

4. Schwartz DL. Current progress in adaptive radiationi therapy for head and neck cancer. Curr Oncol Rep. (2012); 14:139-147

5. Zhao L et al. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. (2011);98:23-27

6. Louise B. et al. Adaptive radiotherapy for head and neck cancer reduces the requirement for rescans during treatment due to spinal cord dose. Radiation Oncology (2019)14, Articale number: 189

7. Noble DJ. Anatomical change during radiotherapy for head and neck cancer and its effect on delivered dose to the spinal cord. Radiother Oncol (2019) 130:32-8

8. Ho KF et al. Monitoring dosimetric impact of weight lose with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. Int J Radiat Oncol Biol Phys (2012) 82(3): e375-82

9 Castelli J. et al. Adaptive radiotherapy for head and neck cancer. Acta Oncologica (2018) Vol57.10:1284-1292

10. Brouwer CL et al. Identifying patients who may benefit from adaptive radiotherapy: does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help? Radiiother Oncol. (2015) 115:285-294

11. Wu Q et al. Adaptive replanning strategis accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. (2009) 75:924-932

12. Nishi T. et al. Volume and dosimetric cahnges and initial clinical experience of a two step adative intensity modulated radiation therapy(IMRT) sheme for head and neck cancer. Radiother Oncol. (2013) 106:85-89.

13. Duma MN. et al. Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlenther Onkol. (2012)18:243-247

14. Zhang P et al. Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer. Radiother Oncol. (2016) 120:41-47

15. O' Danial JC et al. Parotid gland dose in intensity modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys (2007) 69:1290-1296.

16. Hunter KU et al. Parotid glands dose effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head and neck cancer. Int J Radiat Oncol Biols Physc(2013) 87:676 682

17. Noel G. Antonii D. Organs at risk radiation dose constraints. Cancer Radiother. (2022) 26:59-75

18. Lee AW et al. International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. (2019) 105:567-580

19. Lowther NJ et al. Quantifying the dose accumulation uncertainty after deformable image registration in head and neck radiotherapy. Radiother Oncol. (2020) 143:117.125

318

Proffered Paper